Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin -1-yl)thieno(2,3-d)pyrimidine

Details for Australian Patent Application No. 2007309718 (hide)

Owner Dynogen Pharmaceuticals, Inc.

Inventors Cooper, Martin Ian; Frampton, Christopher Stephen

Agent Shelston IP

Pub. Number AU-A-2007309718

PCT Pub. Number WO2008/051282

Priority 60/808,603 26.05.06 US; 60/788,338 31.03.06 US

Filing date 27 March 2007

Wipo publication date 2 May 2008

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

Event Publications

20 November 2008 PCT application entered the National Phase

  PCT publication WO2008/051282 Priority application(s): WO2008/051282

25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309726-Steroid responsive nucleic acid expression and prediction of disease activity

2007309717-Data modifying bus buffer